Stimmrechtsanteile: Epigenomics AG: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] wi.


31.07.20 11:40
Meldung
 

DGAP Voting Rights Announcement: Epigenomics AG
Epigenomics AG: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution

31.07.2020 / 11:35
Dissemination of a Voting Rights Announcement transmitted by DGAP - a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.


Notification of Major Holdings

<Details of issuer
Name: Epigenomics AG
Street: Geneststraße 5
Postal code: 10829
City: Berlin
Germany
Legal Entity Identifier (LEI): 549300X1C4U862NDLN97

2. Reason for notification
  Acquisition/disposal of shares with voting rights
  Acquisition/disposal of instruments
  Change of breakdown of voting rights
X Other reason:
Notification is triggered due to the non application of the Custody Exemption available under Sect. 36 Para. 3 No. 2 WpHG

3. Details of person subject to the notification obligation
Legal entity: Morgan Stanley
City of registered office, country: Wilmington, Delaware, United States of America (USA)

4. Names of shareholder(s)
holding directly 3% or more voting rights, if different from 3.
Morgan Stanley & Co. LLC

5. Date on which threshold was crossed or reached:
27 Jul 2020

6. Total positions
  % of voting rights attached to shares
(total of 7.a.)
% of voting rights through instruments
(total of 7.b.1 + 7.b.2)
Total of both in %
(7.a. + 7.b.)
Total number of voting rights pursuant to Sec. 41 WpHG
New 6.45 % 0.02 % 6.47 % 47129846
Previous notification 3.35 % 0.02 % 3.36 % /

7. Details on total positions
a. Voting rights attached to shares (Sec. 33, 34 WpHG)
ISIN Absolute In %
  Direct
(Sec. 33 WpHG)
Indirect
(Sec. 34 WpHG)
Direct
(Sec. 33 WpHG)
Indirect
(Sec. 34 WpHG)
DE000A11QW50 0 3039945 0.00 % 6.45 %
Total 3039945 6.45 %

b.1. Instruments according to Sec. 38 (1) no. 1 WpHG
Type of instrument Expiration or maturity date Exercise or conversion period Voting rights absolute Voting rights in %
Right of recall over securities lending agreements at any time at any time 7919 0.02 %
    Total 7919 0.02 %

b.2. Instruments according to Sec. 38 (1) no. 2 WpHG
Type of instrument Expiration or maturity date Exercise or conversion period Cash or physical settlement Voting rights absolute Voting rights in %
0 0.00 %
      Total 0 0.00 %

8. Information in relation to the person subject to the notification obligation
  Person subject to the notification obligation is not controlled nor does it control any other undertaking(s) that directly or indirectly hold(s) an interest in the (underlying) issuer (1.).
X Full chain of controlled undertakings starting with the ultimate controlling natural person or legal entity:

Name % of voting rights (if at least 3% or more) % of voting rights through instruments (if at least 5% or more) Total of both (if at least 5% or more)
Morgan Stanley % % %
Morgan Stanley Capital Management, LLC % % %
Morgan Stanley Domestic Holdings, Inc. % % %
Morgan Stanley & Co. LLC 6.45 % % 6.47 %

9. In case of proxy voting according to Sec. 34 para. 3 WpHG
(only in case of attribution of voting rights in accordance with Sec. 34 para. 1 sent. 1 No. 6 WpHG)

Date of general meeting:
Holding total positions after general meeting (6.) after annual general meeting:
Proportion of voting rights Proportion of instruments Total of both
% % %

10. Other explanatory remarks:
 

Date
31 Jul 2020



31.07.2020 The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
Archive at www.dgap.de


Language: English
Company: Epigenomics AG
Geneststraße 5
10829 Berlin
Germany
Internet: www.epigenomics.com

 
End of News DGAP News Service

1107553  31.07.2020 

fncls.ssp?fn=show_t_gif&application_id=1107553&application_name=news&site_id=ariva


 

Breaking News


Kurs- und weitere Informationen zum Thema:

Epigenomics

Aktuelle Diskussionen zum Thema:

Epigenomics auf dem Weg zur ... (23.10.21)
EPI Übernahme - Wir halten ... (21.10.21)
Epigenomics - Nach Kurssturz v. ... (25.04.21)

Aktuelle Nachrichten zum Unternehmen:

Prime Standard | Epigenomics: Fin. (07.10.21)
Epigenomics: Augen auf! (11.08.21)
Epigenomics: Das Ende oder geht . (28.07.21)
Epigenomics: Ein sicheres Investme. (26.04.21)
Epigenomics: Ist dies wirklich Ihr G. (10.04.21)

Alle Nachrichten zum Unternehmen

Aktuelle Analysen zu den Unternehmen:

Epigenomics
Weitere Meldungen
 
31.07 Marshal Lion Financial Group.
31.07 Directors' Dealings: FCR Imm.
31.07 ADM Energy PLC: Appointm.
31.07 DGAP-NVR: IMMOFINANZ A.
31.07 Logwin AG: Logwin angesic.
31.07 Stimmrechtsanteile: Epigenom.
31.07 Eve Sleep plc: Holding in Co.
31.07 Zulassungsfolgepflichten: Lin.
31.07 Directors' Dealings: Baader B.
31.07 Directors' Dealings: ADVA .
31.07 MediCoronabedingt vorsorglic.
31.07 Directors' Dealings: ADVA .
31.07 Stimmrechtsanteile: Philion S.
31.07 EQS-News: Nordea Bank Ab.
31.07 Directors' Dealings: Baader B.
31.07 132 Berufseinsteiger starten.
31.07 DGAP-NVR: Fresenius SE &.
31.07 Veränderungen im Vorstand .
31.07 Stimmrechtsanteile: MorphoSy.
31.07 Baumot Group veröffentlicht .
31.07 Benjamin Schmid ab August.
31.07 Hardman & Co Research: Q.
31.07 KERAMUNDO: Handelsblatt: .
31.07 OTI Greentech AG: OTI Gre.
31.07 CR Capital Real Estate AG.
31.07 Directors' Dealings: Krones A.
31.07 Directors' Dealings: Vonovia .
31.07 Mynaric stellt alle Geschäfts.
31.07 Stimmrechtsanteile: Epigenom.
31.07 Stimmrechtsanteile: Bertrandt.


Umfrage
 
Welche Social Networks nutzen Sie meistens?
Facebook
keine
Twitter
Xing
Linked in
Youtube
myspace
Google+
Wikipedia
andere


Stimmen: 96967 , Ergebnis


Kurssuche
Status: nicht eingeloggt

Registrieren | Passwort vergessen?
 
 
Im Bereich Nachrichten:
BioNTech: Knackt die Aktie nun die nächste Marke?
Experte: Stefan Hofmann, STOCK-WORLD
Kolumnen
DAX Index X-Sequentials ...
Devin Sage, Technische-X-Analyse.de (24.10.21)
Experte: Devin Sage, Technische-X-Analyse.de
DAX-Chartanalyse ...
Karsten Kagels, (24.10.21)
Experte: Karsten Kagels,
Silber – vieles spricht für ...
Jörg Schulte, JS-Research (24.10.21)
Experte: Jörg Schulte, JS-Research
(K)eine Glaubensfrage
wikifolio.com, (24.10.21)
Experte: wikifolio.com,
„Wir spüren die ...
HypoVereinsbank onema., (24.10.21)
Experte: HypoVereinsbank onemarkets,
Neue Kaufsignale für den ...
Claus Vogt, (24.10.21)
Experte: Claus Vogt,
Fonds: Am liebsten öko
Redaktion boerse-frankf., Deutsche Börse AG (24.10.21)
Experte: Redaktion boerse-frankfurt.de, Deutsche Börse AG
Chartbook: Silber, die ...
Miningscout.de, (24.10.21)
Experte: Miningscout.de,
Keine Angst vor dem ...
Frank Schäffler, (24.10.21)
Experte: Frank Schäffler,
Eleving Group S. A. nimmt ...
EUWAX Trends, Börse Stuttgart (24.10.21)
Experte: EUWAX Trends, Börse Stuttgart
STAGFLATIO... – ...
Benjamin Summa, pro aurum (23.10.21)
Experte: Benjamin Summa, pro aurum
Skepsis der ...
Sven Weisenhaus, Stockstreet GmbH (23.10.21)
Experte: Sven Weisenhaus, Stockstreet GmbH
Niquet's World
Neues vom Portal
 
Welche ist die günstigste Methode, um online Zahlungen zu erhalten?
Letzte Börsen-Meldung
 
Letzte Börsen-Analyse
 
Top-Klicks News
 
Top-Klicks Analysen